Beth Monsebroten
Family · Hot Springs, SDNPI 1336495407
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AstraZeneca accounts for 61.6% of it on its own, with 17 other manufacturers making up the rest. Among family clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $33.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$315
- Harmony Biosciences LLC$179
- Sanofi$160
- Verona Pharma, Inc.$123
- Boehringer Ingelheim$113
- plus $808 from 12 others
What the payments were for
- Food & beverage$4,17094%
- Education$2446%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $2,717 |
| GSK | 23 | $315 |
| Harmony Biosciences LLC | 5 | $179 |
| Sanofi | 7 | $160 |
| Verona Pharma, Inc. | 6 | $123 |
| Boehringer Ingelheim | 5 | $113 |
| Actelion Pharmaceuticals US, Inc. | 4 | $109 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Mylan Specialty L.p. | 4 | $93 |
| Insmed, Inc. | 5 | $91 |
| ZOLL Respicardia, Inc. | 4 | $86 |
| Baxter Healthcare | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Inspire Medical Systems, Inc. | 3 | $69 |
| Viatris Specialty LLC | 2 | $45 |
| Bayer | 1 | $28 |
| Lilly USA, LLC | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,414 in reported general payments places this provider in the 95th percentile of 588 family providers in South Dakota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 483 | $342,521 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 180 | $120,683 |
| Spiriva RespimatTiotropium Bromide | 45 | $30,403 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 37 | $18,781 |
| Spiriva HandihalerTiotropium Bromide | 37 | $18,648 |
| Breo ElliptaFluticasone/Vilanterol | 36 | $15,315 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 17 | $11,049 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $9,527 |
| SymbicortBudesonide/Formoterol Fumarate | 31 | $8,680 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 248 | $7,815 |
| Incruse ElliptaUmeclidinium Bromide | 18 | $7,551 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 43 | $7,285 |
| Ventolin HfaAlbuterol Sulfate | 121 | $7,028 |
| DuleraMometasone/Formoterol | 17 | $6,083 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 57 | $6,045 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $315 | $374,912557 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,717 | $129,363211 claims |
| Boehringer IngelheimSpiriva Respimat, Combivent Respimat, Stiolto Respimat | $113 | $60,23399 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 588 family providers in South Dakota.
Other family in Hot Springs
- Brittany WangsnessSioux Falls$79K
- Stephanie PreisterSioux Falls$12K
- Claudia HouglandRapid City$9K
- Maria AzpeitiaDakota Dunes$8K
- Michelle VanhoveSioux Falls$7K
- Sandra EricksonHerreid$7K
- Melissa OwensRapid City$6K
- Heidi FurthSioux Falls$6K
- Tabitha AmmannSioux Falls$6K
- Michelle BrandenburgHuron$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.